| Product NDC: | 0075-8005 |
| Proprietary Name: | TAXOTERE |
| Non Proprietary Name: | Docetaxel |
| Active Ingredient(s): | 80 mg/4mL & nbsp; Docetaxel |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION, CONCENTRATE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0075-8005 |
| Labeler Name: | sanofi-aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020449 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100802 |
| Package NDC: | 0075-8005-01 |
| Package Description: | 1 VIAL, GLASS in 1 CARTON (0075-8005-01) > 8 mL in 1 VIAL, GLASS |
| NDC Code | 0075-8005-01 |
| Proprietary Name | TAXOTERE |
| Package Description | 1 VIAL, GLASS in 1 CARTON (0075-8005-01) > 8 mL in 1 VIAL, GLASS |
| Product NDC | 0075-8005 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Docetaxel |
| Dosage Form Name | INJECTION, SOLUTION, CONCENTRATE |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20100802 |
| Marketing Category Name | NDA |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | DOCETAXEL |
| Strength Number | 80 |
| Strength Unit | mg/4mL |
| Pharmaceutical Classes |